Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats
Frontiers in Pharmacology · 28.08.2023 · 14
DOI: 10.3389/fphar.2023.1146960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 28.08.2023. Verfasst von Xiying Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Diabetes and Angiopathy, Xianning Medical College, Medical Research Institute, Hubei University of Science and Technology, Xi…. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
One of the typical symptoms of diabetes mellitus patients was memory impairment, which was followed by gradual cognitive deterioration and for which there is no efficient treatment. The anti-diabetic incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) were demonstrated to have highly neuroprotective benefits in animal models of AD. We wanted to find out how the GLP-1/GIP dual agonist tirzepatide affected diabetes’s impairment of spatial learning memory.
Methods
High fat diet and streptozotocin injection-induced diabetic rats were injected intraperitoneally with Tirzepatide (1.35 mg/kg) once a week. The protective effects were assessed using the Morris water maze test, immunofluorescence, and Western blot analysis. Golgi staining was adopted for quantified dendritic spines.
Results
Tirzepatide significantly improved impaired glucose tolerance, fasting blood glucose level, and insulin level in diabetic rats. Then, tirzepatide dramatically alleviated spatial learning and memory impairment, inhibited Aβ accumulation, prevented structural damage, boosted the synthesis of synaptic proteins and increased dendritic spines formation in diabetic hippocampus. Furthermore, some aberrant changes in signal molecules concerning inflammation signaling pathways were normalized after tirzepatide treatment in diabetic rats. Finally, PI3K/Akt/GSK3β signaling pathway was restored by tirzepatide.
Conclusion
Tirzepatide obviously exerts a protective effect against spatial learning and memory impairment, potentially through regulating abnormal insulin resistance and inflammatory responses.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hubei Key Laboratory of Diabetes and Angiopathy, Xianning Medical College, Medical Research Institute, Hubei University of Science and Technology, Xianning, China.
- Pharmacy College, Xianning Medical College, Hubei University of Science and Technology, Xianning, China.
Zitieren
APA
Guo, X., Lei, M., Zhao, J., Wu, M., Ren, Z., Yang, X., Ouyang, C., Liu, X., Liu, C., & Chen, Q. (2023). Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1146960
Vancouver
Guo X, Lei M, Zhao J, Wu M, Ren Z, Yang X, et al. Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1146960
BibTeX
@article{Guo2023,
author = {Guo, Xiying and Lei, Min and Zhao, Jiangyan and Wu, Min and Ren, Zhanhong and Yang, Xiaosong and Ouyang, Changhan and Liu, Xiufen and Liu, Chao and Chen, Qingjie},
title = {Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1146960}
}
EUVIMED